How much does Seleniso cost after insurance?

Selinexor (Selinexor), this targeted therapy drug for relapsed and refractory multiple myeloma, relies on its unique mechanism of action, that is, by inhibiting the function of XPO1 protein, interfering with molecular transport within cancer cells, effectively curbing the proliferation of tumor cells. However, its higher drug costs have deterred many patients. Fortunately, in China, Seleniso has been successfully included in the medical insurance system, bringing real economic burden relief to patients.

After being included in the medical insurance, patients who meet the regulations can purchase Seleniso with their medical insurance card and enjoy a certain percentage of reimbursement. This policy varies by region. Patients can consult the local hospital pharmacy or medical insurance department for specific reimbursement ratios and conditions. In general, the implementation of the medical insurance policy has made the cost of Seleniso treatment less burdensome for patients, especially for cancer patients who require long-term medication. This is undoubtedly a huge boon.

In the Chinese market, the selling price of Seleniso ranges from RMB 5,000 to more than RMB 10,000 per box. The specific price will fluctuate depending on the region and hospital. Patients can check detailed prices through the hospital pharmacy in their area and calculate the actual expenses they need to bear based on the medical insurance reimbursement policy. Although the original price is high, after medical insurance reimburses it, the actual burden on patients is greatly reduced.

The price of Seleniso is affected by many factors, including market demand, manufacturers, regional policies, etc. As innovative drugs, their global prices are generally high. However, in China, with the inclusion of medical insurance policies, patients’ treatment burden has been effectively alleviated. In addition, it is recommended that patients purchase drugs through medical insurance designated hospital pharmacies or formal drug procurement channels to ensure that the source of drugs is regular and at the same time enjoy the benefits of medical insurance reimbursement.

xa0

Reference materials:

National Medical Products Administration (NMPA) official website. Seleniso approval information:https://www.nmpa.gov.cn